Project Grant R03OD039972

Award Date 6/10/25
Completion Date 5/31/26
Dollars Obligated $1
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Ohio, USA
Similar Awards
This $506,984 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to investigate the role of the LRP1 gene in the development of congenital heart disease (CHD). The primary objectives are to: Examine the deployment and migration of cardiac neural crest cells (CNCCs) and their dependence on LRP1 using in vitro and in vivo cell lineage fate mapping analysis. Investigate the cellular and molecular...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $802,762 to The University of Texas Southwestern Medical Center to interpret the impact of genetic variants, both coding and non-coding, on congenital heart disease (CHD). The key objectives are to: 1) Define the transcription factors and gene regulatory networks underlying human cardiac development; 2) Identify and characterize...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $487,567 to Indiana University to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects (CHDs). The research aims to identify genetic variants and biological pathways associated with CHDs, as well as build predictive models leveraging genetic, epigenetic,...
This federal Project Grant award in the amount of $757,089 from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports research to identify novel genes and genetic variants associated with congenital diaphragmatic hernia (CDH) and validate their role in mouse models. The awardee, Jackson Laboratory, will use genome data from a large CDH patient cohort to prioritize candidate genes and variants for validation in...
This $161,500 Project Grant was awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant is intended to establish basic science-clinical collaborations to understand the molecular mechanisms of heterotaxy, a severe form of congenital heart disease that affects 3-4% of patients with congenital heart defects. The funding will support research at the University of Virginia to...
This Project Grant award of $311,000 from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund the development of comprehensive de novo variant (DNV) callsets for the Gabriella Miller Kids First Pediatric Research Program's birth defects dataset. The key products to be delivered under this 2-year award include: 1) Identification of new genes involved in birth defects through the...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $168,480 to Ann & Robert H. Lurie Children's Hospital of Chicago to study how prenatal care utilization pathways impact postnatal healthcare outcomes for publicly insured children with congenital heart defects (CHDs). The key objectives are to: 1) identify common prenatal care utilization pathways leading to delivery at a CHD surgical...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $844,386 to support research on the genetic landscape of childhood interstitial and diffuse lung diseases (CHILD). The key objectives are to: 1) Define molecular profiles of 300 CHILD lung biopsy samples to identify patient clusters with similar underlying causes, 2) Analyze whole exome sequence data from 400 children with...
This Cooperative Agreement award, with a total funding amount of $650,398.00, was provided by the National Center on Birth Defects and Developmental Disabilities, part of the Centers for Disease Control and Prevention (CDC), under the Disabilities Prevention Federal Grant Program (CFDA 93.184). The award aims to advance the surveillance of congenital heart defects (CHD) by utilizing informatics and data science approaches to improve the health of children, adolescents, and adults living with...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to assess variants of uncertain significance in the intellectual disability gene ANKRD17. The $265,500 award to The Children's Hospital Corporation (dba Boston Children's Hospital) will fund an efficient and innovative strategy to evaluate variants in ANKRD17, a gene that causes...

UNCOVERING INCOMPLETE PENETRANCE GENES IN CONGENITAL HEART DISEASE BY INTEGRATIVE ANALYSIS OF COMMON FUND DATA - PROJECT SUMMARY CONGENITAL HEART DISEASE (CHD) IS THE MOST COMMON BIRTH DEFECT AND A LEADING CAUSE OF MORTALITY IN CHILDREN. DESPITE A WELL-ESTABLISHED HERITABLE COMPONENTTO THIS DISORDER, GENETIC TESTINGIS OFTEN UNSUCCESSFUL. SOME 60% OF PATIENTS FAIL TO RECEIVE A MOLECULAR DIAGNOSIS; FOR PATIENTS WITH ISOLATED CHD, THE FAILURE RATE IS CLOSER TO 90%. WITHOUT A PRECISE DIAGNOSIS, IT IS DIFFICULT TO PROVIDE ANY PATIENT WITH AN ACCURATE PROGNOSIS OR PERSONALIZED INTERVENTIONS. THE MAIN REASON THAT DIAGNOSTIC TESTING FAILS IS THAT OUR KNOWLEDGE OF THE GENETIC UNDERPINNINGS OF CHD REMAINS WOEFULLY INCOMPLETE. CHD IS NOT ONLY GENETICALLY HETEROGENEOUS, BUT ALSO NOTORIOUS FOR INCOMPLETE PENETRANCE (VARIANTS THAT DO NOT ALWAYS CAUSE A CONDITION). IN THIS PROPOSAL WE AIM TO QUANTIFY THE ROLE OF INCOMPLETE PENETRANCE IN CHD RISK GENES. WE WILL SOURCE A LARGE COHORT OF CHD FAMILIES FROMTHE GABRIELLA MILLER KIDS FIRST RESOURCE, THE UNDIAGNOSED DISEASE NETWORK, GENOMICS ENGLAND, AND AN INTERNAL RESEARCH STUDY AND PERFORMTWO COMPLEMENTARY ANALYSES TO RANK CHD GENES. FIRST, WE WILL APPLY A GENETIC ASSOCIATION STUDY OF CHD PROBANDS TO PRIORITIZE GENES WITH AN INCREASED BURDEN OF RARE GENETIC VARIATION AMONG CHD PATIENTS IRRESPECTIVE OF THE INHERITANCE PATTERN. THIS WILL BE ACHIEVED THROUGH AN INNOVATIVE NEW RESOURCE: A REMOTE CONTROL DATABASE OF 40,000 HEALTHY, DIVERSE CONTROLS AND A METHOD TO SECURELY SELECT MATCHED CONTROLS FOR ANY GIVEN CASE COHORT. SECOND, WE WILL PERFORMPEDIGREEANALYSIS OF ALL CHD FAMILIES TO IDENTIFY GENES IN WHICH RARE LARGE-EFFECT VARIANTS SEGREGATE WITH DISEASE. FINALLY, WE WILL COMBINE THE RESULTS OF BOTH STRATEGIES INTO A SINGLE MASTER TABLE OF CHD GENES AND USE THE SEGREGATION PATTERNS OBSERVED IN ALL FAMILIES TO QUANTIFY THE EXTENT OF INCOMPLETE PENETRANCE. WE EXPECT OUR RESULTS WILL SERVE AS A REFERENCE FOR THE DIAGNOSTIC INITIATIVES IN CHD AND WILL INFORM CLINICAL GENETICISTS ABOUT THE LIKELIHOOD OF DISEASE CAUSALITY FOR GENES CHALLENGED BY INCOMPLETE PENETRANCE. OUR RESULTS SHOULD PROVIDE A FRAMEWORK FOR INTEGRATING ASSOCIATION AND SEGREGATION ANALYSES THAT COULD BE ADAPTED TO OTHER GENETICALLY HETEROGENEOUS CONDITIONS.

Posted 6/10/25, 12:00 AM